Stalin Vilcarromero
Research Subjects
Stalin Vilcarromero has a total of 323 co-authors. Here are the top co-authors by number of shared publications:
Amy C. Morrison
Affiliations U.S. Naval Medical Research Unit No. 6, Lima and Iquitos, Perú, Department of Entomology and Nematology, University of California, Davis, Davis, California, United States of America
11 shared publicationsEric S. Halsey
Affiliation U.S. Naval Medical Research Unit No. 6, Lima and Iquitos, Peru
9 shared publicationsTadeusz J. Kochel
Affiliation U.S. Naval Medical Research Unit No. 6, Lima and Iquitos, Peru
9 shared publicationsBrett M. Forshey
US Naval Medical Research Unit No. 6 Lima and Iquitos, Peru
8 shared publicationsClaudio Rocha
U.S. Naval Medical Research Unit No. 6, Lima, Peru
8 shared publicationsThomas W. Scott
Department of Entomology and Nematology, University of California Davis
8 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 65
Oropouche virus disease across Latin America during the 2023–2025 epidemic: a multi-country case series
- 12 November 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 65
Open AccessOropouche virus disease across Latin America during the 2023–2025 epidemic: a multi-country case series
- 30 September 2026
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 26 (3) , 91-102
Antibiotic use and factors associated with inappropriate prescribing among hospitalized patients: a cross-sectional study in Peru
Introduction: Antibiotic use is common in clinical practice, and inappropriate prescribing may increase the risk of the development of multidrug-resistant pathogens. Objective: To determine the point prevalence of antibiotic use and assess the association between culture ordering and appropriate antibiotic prescribing. Methods: A cross-sectional study was conducted among adult inpatients at Hospital Nacional Edgardo Rebagliati Martins in Lima, Peru, in October 2023, using World Health Organization (WHO) methodology. To assess factors associated with inappropriate antibiotic prescribing, Poisson regression models with robust variance were fitted to estimate adjusted prevalence ratios (aPRs) and their corresponding 95% confidence intervals (CIs). Results: Among the 644 patients included, 249 (38.7%) were receiving antibiotics, and 57.8% of prescriptions were inappropriate. Meropenem was the most frequently prescribed antibiotic, and antibiotics in the AWaRe Watch group predominated, accounting for 73.5% of prescriptions. Culture ordering before antibiotic initiation was associated with a lower prevalence of inappropriate prescribing (aPR = 0.77; 95% CI: 0.60–0.99), whereas community-acquired infections were associated with a higher prevalence of inappropriate prescribing (aPR = 1.38; 95% CI: 1.06–1.79). Conclusions: Nearly four in ten inpatients were receiving antibiotics, and more than half of prescriptions were inappropriate, with antibiotics in the AWaRe Watch group predominating. Culture ordering before antibiotic initiation was associated with a lower prevalence of inappropriate antibiotic prescribing.
- 30 September 2026
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 26 (3) , 91-102
Antibiotic use and factors associated with inappropriate prescribing among hospitalized patients: a cross-sectional study in Peru
Introduction: Antibiotic use is common in clinical practice, and inappropriate prescribing may increase the risk of the development of multidrug-resistant pathogens. Objective: To determine the point prevalence of antibiotic use and assess the association between culture ordering and appropriate antibiotic prescribing. Methods: A cross-sectional study was conducted among adult inpatients at Hospital Nacional Edgardo Rebagliati Martins in Lima, Peru, in October 2023, using World Health Organization (WHO) methodology. To assess factors associated with inappropriate antibiotic prescribing, Poisson regression models with robust variance were fitted to estimate adjusted prevalence ratios (aPRs) and their corresponding 95% confidence intervals (CIs). Results: Among the 644 patients included, 249 (38.7%) were receiving antibiotics, and 57.8% of prescriptions were inappropriate. Meropenem was the most frequently prescribed antibiotic, and antibiotics in the AWaRe Watch group predominated, accounting for 73.5% of prescriptions. Culture ordering before antibiotic initiation was associated with a lower prevalence of inappropriate prescribing (aPR = 0.77; 95% CI: 0.60–0.99), whereas community-acquired infections were associated with a higher prevalence of inappropriate prescribing (aPR = 1.38; 95% CI: 1.06–1.79). Conclusions: Nearly four in ten inpatients were receiving antibiotics, and more than half of prescriptions were inappropriate, with antibiotics in the AWaRe Watch group predominating. Culture ordering before antibiotic initiation was associated with a lower prevalence of inappropriate antibiotic prescribing.
- Open Access
Efficacy of an attractive lethal ovitrap to reduce populations of Aedes mosquitoes: a controlled trial in Iquitos, Peru
Introduction: Dengue, one of the most important arboviral infections worldwide, is transmitted primarily by the mosquito Aedes aegypti , a vector closely associated with human habitations. Because vector control is the primary prevention strategy for this disease novel tools are urgently needed. We evaluated an Attractive Lethal OviTrap (ALOT) that targets epidemiologically relevant gravid female mosquitoes for public health impact against dengue disease. Methods: We conducted a proof-of-concept field efficacy trial in the Amazonian city of Iquitos, Peru, to quantify the reduction of vector density, parity, and sex ratio and symptomatic human dengue infection over a 3.5 year follow-up period. After three baseline entomological surveys in core (753 houses), and buffer (1,549 houses) areas where traps were placed in and around homes, and a control (1,233 houses) area without traps, entomological surveys were carried out every 2 months, and household residents were monitored for dengue disease 3 times a week. Trap maintenance was conducted at 2-3 week intervals by study staff during the first 2.5 years and by residents in the final year. Results: Total and female Ae. aegypti abundance demonstrated a strong initial effect with 52% and 47% fewer mosquitoes after trap placement, respectively (Total: RR = 0.48, 95% CI: 0.40 – 0.58, p < 0.001; Females: RR = 0.53, 95% CI: 0.43 – 0.66, p < 0.001). The effect diminished significantly, however, over the study period (interaction coefficient = 0.035 per month, p < 0.001; interaction coefficient = 0.030 per month, p < 0.001). Female-to-male ratio decreased after trap deployment and impact on non- Aedes abundance was like that of Aedes . Cumulative symptomatic dengue incidence was 1.40% (95% CI: 1.00%-1.70%) in the ALOT area versus 3.20% (95% CI: 2.60%-3.80%) in the control area, a 56% relative reduction (log-rank χ²=30.0, pAedes aegypti, the most important species involved, has a unique biology living in containers associated with households. New methods to control this mosquito are needed and we present our evaluation of a novel trap called the Attractive Lethal OviTrap (ALOT) that targets older female mosquitoes that are the most important for dengue disease transmission. We conducted a trial in the Amazonian city of Iquitos, Peru, to measure reductions in mosquito numbers, age, and sex ratio and symptomatic human dengue infections over a 3.5 years. After baseline entomological surveys prior to placing ALOT traps in homes in a treatment area, which included a central core area with 753 houses and a protective buffer area with 1,549 houses areas. We also had a control area without any traps in 1,233 houses. Mosquito surveys were carried out every 2 months, and household residents were monitored for dengue disease 3 times per week. Trap maintenance was conducted at 2 - 3 week intervals by study staff during the first 2.5 years and by residents in the final year. The number of all Ae. aegypti were initially reduced by 52% after trap placement whereas females were reduced by 47%. The effect diminished significantly, however, over the study period. Female-to-male ratio decreased after trap deployment and impact on other mosquito species was like that of Aedes . Dengue incidence was 56% less in the area with traps compared to the control area, estimating that participants in the intervention area on average remained dengue-free for 15.5 additional days. The ALOT strategy functioned as predicted, decreasing but not eliminating female mosquitos and had a clear public health impact, lowering dengue disease in areas where traps were deployed. Our study also illustrates the challenges associated with conducting large-scale vector control trials and the need to consider programmatic implementation early in the process of bringing a new product to market.
Open AccessEfficacy of an attractive lethal ovitrap to reduce populations of Aedes mosquitoes: a controlled trial in Iquitos, Peru
Introduction: Dengue, one of the most important arboviral infections worldwide, is transmitted primarily by the mosquito Aedes aegypti , a vector closely associated with human habitations. Because vector control is the primary prevention strategy for this disease novel tools are urgently needed. We evaluated an Attractive Lethal OviTrap (ALOT) that targets epidemiologically relevant gravid female mosquitoes for public health impact against dengue disease. Methods: We conducted a proof-of-concept field efficacy trial in the Amazonian city of Iquitos, Peru, to quantify the reduction of vector density, parity, and sex ratio and symptomatic human dengue infection over a 3.5 year follow-up period. After three baseline entomological surveys in core (753 houses), and buffer (1,549 houses) areas where traps were placed in and around homes, and a control (1,233 houses) area without traps, entomological surveys were carried out every 2 months, and household residents were monitored for dengue disease 3 times a week. Trap maintenance was conducted at 2-3 week intervals by study staff during the first 2.5 years and by residents in the final year. Results: Total and female Ae. aegypti abundance demonstrated a strong initial effect with 52% and 47% fewer mosquitoes after trap placement, respectively (Total: RR = 0.48, 95% CI: 0.40 – 0.58, p < 0.001; Females: RR = 0.53, 95% CI: 0.43 – 0.66, p < 0.001). The effect diminished significantly, however, over the study period (interaction coefficient = 0.035 per month, p < 0.001; interaction coefficient = 0.030 per month, p < 0.001). Female-to-male ratio decreased after trap deployment and impact on non- Aedes abundance was like that of Aedes . Cumulative symptomatic dengue incidence was 1.40% (95% CI: 1.00%-1.70%) in the ALOT area versus 3.20% (95% CI: 2.60%-3.80%) in the control area, a 56% relative reduction (log-rank χ²=30.0, pAedes aegypti, the most important species involved, has a unique biology living in containers associated with households. New methods to control this mosquito are needed and we present our evaluation of a novel trap called the Attractive Lethal OviTrap (ALOT) that targets older female mosquitoes that are the most important for dengue disease transmission. We conducted a trial in the Amazonian city of Iquitos, Peru, to measure reductions in mosquito numbers, age, and sex ratio and symptomatic human dengue infections over a 3.5 years. After baseline entomological surveys prior to placing ALOT traps in homes in a treatment area, which included a central core area with 753 houses and a protective buffer area with 1,549 houses areas. We also had a control area without any traps in 1,233 houses. Mosquito surveys were carried out every 2 months, and household residents were monitored for dengue disease 3 times per week. Trap maintenance was conducted at 2 - 3 week intervals by study staff during the first 2.5 years and by residents in the final year. The number of all Ae. aegypti were initially reduced by 52% after trap placement whereas females were reduced by 47%. The effect diminished significantly, however, over the study period. Female-to-male ratio decreased after trap deployment and impact on other mosquito species was like that of Aedes . Dengue incidence was 56% less in the area with traps compared to the control area, estimating that participants in the intervention area on average remained dengue-free for 15.5 additional days. The ALOT strategy functioned as predicted, decreasing but not eliminating female mosquitos and had a clear public health impact, lowering dengue disease in areas where traps were deployed. Our study also illustrates the challenges associated with conducting large-scale vector control trials and the need to consider programmatic implementation early in the process of bringing a new product to market.
- Open Access
- 30 June 2026
- Published by Actas Peruanas de Anestesiologia in ACTAS PERUANAS DE ANESTESIOLOGIA
- Vol. 24 (2) , 106-112
Reporte de caso: anestesia para colporrafia en paciente con paraparesia espástica tropical por HTLV-1.
Introduction Human T-lymphotropic virus type 1 (HTLV-1) infection primarily affects T lymphocytes and is linked to tropical spastic paraparesis, a chronic progressive myelopathy. This condition poses anesthetic challenges for which available evidence remains scarce. Case presentation A 59-year-old woman with spastic paraparesis secondary to HTLV-1 was scheduled for anterior colporrhaphy for stage II POP-Q genital prolapse (leading point Ba). Intravenous sedation with spontaneous ventilation (midazolam, fentanyl, and propofol) was chosen to avoid a neuraxial approach and to allow postoperative neurological assessment. The procedure was uneventful, without hemodynamic instability or respiratory events. The patient recovered well, with no change from her baseline neurological status, and was discharged the same day. Discussion The technique was selected to avoid neuraxial anesthesia, which is debated in patients with pre-existing myelopathy because of the theoretical risk of deficit progression and the difficulty of attributing new symptoms to the procedure. Intravenous sedation with spontaneous ventilation preserved airway reflexes and permitted early neurological evaluation. Available evidence is limited to isolated reports, with no consensus on the safety of neuraxial techniques in this population. Conclusion Intravenous sedation with spontaneous ventilation proved a safe and effective alternative in this patient, avoiding neuraxial manipulation while preserving neurological assessment. Further reports are needed to guide anesthetic management in HTLV-1--associated myelopathy.
- 30 June 2026
- Published by Actas Peruanas de Anestesiologia in ACTAS PERUANAS DE ANESTESIOLOGIA
- Vol. 24 (2) , 106-112
Open AccessReporte de caso: anestesia para colporrafia en paciente con paraparesia espástica tropical por HTLV-1.
Introduction Human T-lymphotropic virus type 1 (HTLV-1) infection primarily affects T lymphocytes and is linked to tropical spastic paraparesis, a chronic progressive myelopathy. This condition poses anesthetic challenges for which available evidence remains scarce. Case presentation A 59-year-old woman with spastic paraparesis secondary to HTLV-1 was scheduled for anterior colporrhaphy for stage II POP-Q genital prolapse (leading point Ba). Intravenous sedation with spontaneous ventilation (midazolam, fentanyl, and propofol) was chosen to avoid a neuraxial approach and to allow postoperative neurological assessment. The procedure was uneventful, without hemodynamic instability or respiratory events. The patient recovered well, with no change from her baseline neurological status, and was discharged the same day. Discussion The technique was selected to avoid neuraxial anesthesia, which is debated in patients with pre-existing myelopathy because of the theoretical risk of deficit progression and the difficulty of attributing new symptoms to the procedure. Intravenous sedation with spontaneous ventilation preserved airway reflexes and permitted early neurological evaluation. Available evidence is limited to isolated reports, with no consensus on the safety of neuraxial techniques in this population. Conclusion Intravenous sedation with spontaneous ventilation proved a safe and effective alternative in this patient, avoiding neuraxial manipulation while preserving neurological assessment. Further reports are needed to guide anesthetic management in HTLV-1--associated myelopathy.
- Open Access
- 31 March 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 43 (1) , 132-7
Bacteriemia por Sphingomonas paucimobilis en pacientes pediátricos y adultos de un hospital de referencia del Perú 2020-2024
Sphingomonas paucimobilis es una bacteria ubicua y de baja virulencia que puede causar bacteriemia, especialmente en pacientes inmunocomprometidos. Dada la ausencia de reportes recientes sobre este patógeno y su perfil de resistencia en Perú, esta serie evaluó sus características clínicas y microbiológicas en un hospital de referencia. Se analizaron 6 casos confirmados por hemocultivo entre enero de 2020 y septiembre de 2024 (4 pediátricos, 2 adultos). Todos los pacientes presentaron múltiples factores de riesgo o comorbilidades, con la mayoría utilizando catéter venoso central. La mortalidad observada en la serie fue del 50%. En cuanto a la sensibilidad, dos aislamientos mostraron resistencia a cefalosporinas de tercera y cuarta generación, y a ciprofloxacino, siendo todos sensibles a aminoglucósidos y a otra quinolona como el levofloxacino. S. paucimobilis representa un patógeno emergente, con patrones de resistencia variables que destacan la necesidad de una vigilancia continua y un manejo terapéutico individualizado guiado por antibiograma.
- 31 March 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 43 (1) , 132-7
Open AccessBacteriemia por Sphingomonas paucimobilis en pacientes pediátricos y adultos de un hospital de referencia del Perú 2020-2024
Sphingomonas paucimobilis es una bacteria ubicua y de baja virulencia que puede causar bacteriemia, especialmente en pacientes inmunocomprometidos. Dada la ausencia de reportes recientes sobre este patógeno y su perfil de resistencia en Perú, esta serie evaluó sus características clínicas y microbiológicas en un hospital de referencia. Se analizaron 6 casos confirmados por hemocultivo entre enero de 2020 y septiembre de 2024 (4 pediátricos, 2 adultos). Todos los pacientes presentaron múltiples factores de riesgo o comorbilidades, con la mayoría utilizando catéter venoso central. La mortalidad observada en la serie fue del 50%. En cuanto a la sensibilidad, dos aislamientos mostraron resistencia a cefalosporinas de tercera y cuarta generación, y a ciprofloxacino, siendo todos sensibles a aminoglucósidos y a otra quinolona como el levofloxacino. S. paucimobilis representa un patógeno emergente, con patrones de resistencia variables que destacan la necesidad de una vigilancia continua y un manejo terapéutico individualizado guiado por antibiograma.
- Open Access
- 2 September 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (3) , 252-62
Mortalidad y factores asociados en pacientes postrasplante de células madre: cohorte de dos años en un hospital público del Perú
Objective. To determine mortality and associated factors in patients who received an allogeneic hematopoietic stem cell transplant at the Hospital Nacional Edgardo Rebagliati Martins, between January 2017 and December 2022. Materials and methods. A retrospective cohort study was conducted on patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT) between 2017 and 2022. Death at one hundred days and two years, and its associated factors, were evaluated. Proportional Cox regression models were used. Results. 342 post-HSCT patients were included, with a median age of 23 years (interquartile range: 10 to 39), of whom 53.5% were women. The most frequent diagnosis for the transplant was acute lymphoblastic leukemia at 54.1%. Mortality in the first 100 days post-HSCT was 8.2%, and at two years was 30.4%. In the multivariate regression at one hundred days, factors associated with a higher risk of mortality were age over 50 years (HRa: 6.97; 95% CI: 1.18−41.23), being a recipient of a haploidentical transplant (HRa: 3.57; 95% CI: 1.13−11.24), and sepsis as a complication (HRa: 68.78; 95% CI: 19.32−244.84). In the two-year analysis, acute myeloid leukemia (1.72; IC 95%: 1.08-2.74), haploidentical transplant (HRa:1.81; 95%CI: 1.21-2.72), and disease relapse (HRa: 4.17; 95%CI%: 2.75-6.31) were associated with a higher risk of death. Conclusions. The mortality found was low and similar to that of countries with higher incomes; however, it is necessary to formulate interventions that reduce the incidence of modifiable factors such as sepsis.
- 2 September 2025
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 42 (3) , 252-62
Open AccessMortalidad y factores asociados en pacientes postrasplante de células madre: cohorte de dos años en un hospital público del Perú
Objective. To determine mortality and associated factors in patients who received an allogeneic hematopoietic stem cell transplant at the Hospital Nacional Edgardo Rebagliati Martins, between January 2017 and December 2022. Materials and methods. A retrospective cohort study was conducted on patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT) between 2017 and 2022. Death at one hundred days and two years, and its associated factors, were evaluated. Proportional Cox regression models were used. Results. 342 post-HSCT patients were included, with a median age of 23 years (interquartile range: 10 to 39), of whom 53.5% were women. The most frequent diagnosis for the transplant was acute lymphoblastic leukemia at 54.1%. Mortality in the first 100 days post-HSCT was 8.2%, and at two years was 30.4%. In the multivariate regression at one hundred days, factors associated with a higher risk of mortality were age over 50 years (HRa: 6.97; 95% CI: 1.18−41.23), being a recipient of a haploidentical transplant (HRa: 3.57; 95% CI: 1.13−11.24), and sepsis as a complication (HRa: 68.78; 95% CI: 19.32−244.84). In the two-year analysis, acute myeloid leukemia (1.72; IC 95%: 1.08-2.74), haploidentical transplant (HRa:1.81; 95%CI: 1.21-2.72), and disease relapse (HRa: 4.17; 95%CI%: 2.75-6.31) were associated with a higher risk of death. Conclusions. The mortality found was low and similar to that of countries with higher incomes; however, it is necessary to formulate interventions that reduce the incidence of modifiable factors such as sepsis.
- Open Access
- 3 September 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (3) , 316-20
Meningitis e hipoacusia neurosensorial por Rickettsia sp. en Perú: reporte de caso
We present the case of a young female health worker, resident in a high Andean region of Peru, with recent exposure to farm animals and arthropods, who developed acute febrile undifferentiated syndrome, severe thrombocytopenia and pulmonary and abdominal extravasation. Subsequently, the patient developed meningitis and early onset bilateral neurosensorial hypoacusis and showed reactive serology to acute infection by Rickettsia sp. Epidemiological and clinical considerations in the differential diagnosis for early management are discussed.
- 3 September 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (3) , 316-20
Open AccessMeningitis e hipoacusia neurosensorial por Rickettsia sp. en Perú: reporte de caso
We present the case of a young female health worker, resident in a high Andean region of Peru, with recent exposure to farm animals and arthropods, who developed acute febrile undifferentiated syndrome, severe thrombocytopenia and pulmonary and abdominal extravasation. Subsequently, the patient developed meningitis and early onset bilateral neurosensorial hypoacusis and showed reactive serology to acute infection by Rickettsia sp. Epidemiological and clinical considerations in the differential diagnosis for early management are discussed.
- Open Access
- 25 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0305689
Risk factors associated with dengue complications and death: A cohort study in Peru
Background: Dengue has emerged as an unprecedented epidemic in Peru, and it is anticipated that this issue will escalate further owing to climate change. This study aimed to determine the risk factors associated with death from dengue in patients treated at Hospital II in Pucallpa, Peru. Methodology: This retrospective cohort study collected information from the medical records of patients with a diagnosis of dengue treated at Hospital II Pucallpa-Peru between January 2019 and March 2023. The primary outcome was death, and the secondary outcome was death, development of severe dengue, or Intensive Care Unit (ICU) admission. Cox regression models were used to determine risk factors. Findings: The clinical records of 152 patients were evaluated, with a median age of 27.5 years (interquartile range, 11–45). Among all patients, 29 (19.1%) developed severe dengue, 31 (20.4%) were admitted to the ICU, and 13 (8.6%) died during follow-up. In the survival analysis, bilirubin >1.2 mg/dL was associated with a higher risk of death aHR: 11.38 (95% CI: 1.2 106.8). Additionally, factors associated with poor prognosis included having 1 to 3 comorbidities aRR: 1.92 (1.2 to 3.2), AST ≥251 U/L aRR: 6.79 (2.2 to 21.4), history of previous dengue aRR: 1.84 (1.0 to 3.3), and fibrinogen ≥400 mg/dL aRR: 2.23 (1.2 to 4.1). Significance: Elevated bilirubin was associated with death from dengue, whereas an increase in comorbidities and a history of previous dengue were related to a poor prognosis of the disease. Early identification of severe dengue would be more feasible with improved access to laboratory testing, particularly in tropical areas with a high dengue incidence.
- 25 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0305689
Open AccessRisk factors associated with dengue complications and death: A cohort study in Peru
Background: Dengue has emerged as an unprecedented epidemic in Peru, and it is anticipated that this issue will escalate further owing to climate change. This study aimed to determine the risk factors associated with death from dengue in patients treated at Hospital II in Pucallpa, Peru. Methodology: This retrospective cohort study collected information from the medical records of patients with a diagnosis of dengue treated at Hospital II Pucallpa-Peru between January 2019 and March 2023. The primary outcome was death, and the secondary outcome was death, development of severe dengue, or Intensive Care Unit (ICU) admission. Cox regression models were used to determine risk factors. Findings: The clinical records of 152 patients were evaluated, with a median age of 27.5 years (interquartile range, 11–45). Among all patients, 29 (19.1%) developed severe dengue, 31 (20.4%) were admitted to the ICU, and 13 (8.6%) died during follow-up. In the survival analysis, bilirubin >1.2 mg/dL was associated with a higher risk of death aHR: 11.38 (95% CI: 1.2 106.8). Additionally, factors associated with poor prognosis included having 1 to 3 comorbidities aRR: 1.92 (1.2 to 3.2), AST ≥251 U/L aRR: 6.79 (2.2 to 21.4), history of previous dengue aRR: 1.84 (1.0 to 3.3), and fibrinogen ≥400 mg/dL aRR: 2.23 (1.2 to 4.1). Significance: Elevated bilirubin was associated with death from dengue, whereas an increase in comorbidities and a history of previous dengue were related to a poor prognosis of the disease. Early identification of severe dengue would be more feasible with improved access to laboratory testing, particularly in tropical areas with a high dengue incidence.
- Open Access
- 18 December 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (4) , 493
Diferencias en el impacto del mayor brote epidémico de dengue en la historia del Perú y lecciones aprendidas
- 18 December 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (4) , 493
Open AccessDiferencias en el impacto del mayor brote epidémico de dengue en la historia del Perú y lecciones aprendidas
- Open Access
- 26 September 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (3) , 374-6
Emergencia sanitaria por dengue en el Perú: necesidad de una asignación presupuestal acorde a la situación epidemiológica
- 26 September 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (3) , 374-6
Open AccessEmergencia sanitaria por dengue en el Perú: necesidad de una asignación presupuestal acorde a la situación epidemiológica